Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease

被引:0
|
作者
Lee, Seungwon [1 ,2 ,3 ,4 ]
Shaheen, Abdel Aziz [1 ,2 ,5 ]
Campbell, David J. T. [1 ,5 ,7 ]
Naugler, Christopher [1 ,6 ]
Jiang, Jason [2 ,3 ]
Walker, Robin L. [1 ,2 ]
Quan, Hude [1 ,2 ]
Lee, Joon [1 ,2 ,4 ,7 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada
[2] Univ Calgary, Ctr Hlth Informat, Cumming Sch Med, Calgary, AB, Canada
[3] Alberta Hlth Serv, Calgary, AB, Canada
[4] Univ Calgary, Cumming Sch Med, Data Intelligence Hlth Lab, Calgary, AB, Canada
[5] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[6] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada
[7] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Calgary, AB, Canada
基金
加拿大健康研究院;
关键词
Diabetes mellitus; International classification of diseases; Non-alcoholic fatty liver disease; Routinely collected health data; Health services research; COMORBIDITY INDEX; PREVALENCE;
D O I
10.1186/s12913-024-10634-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundNon-alcoholic fatty liver disease (NAFLD) describes a spectrum of chronic fattening of liver that can lead to fibrosis and cirrhosis. Diabetes has been identified as a major comorbidity that contributes to NAFLD progression. Health systems around the world make use of administrative data to conduct population-based prevalence studies. To that end, we sought to assess the accuracy of diabetes International Classification of Diseases (ICD) coding in administrative databases among a cohort of confirmed NAFLD patients in Calgary, Alberta, Canada.MethodsThe Calgary NAFLD Pathway Database was linked to the following databases: Physician Claims, Discharge Abstract Database, National Ambulatory Care Reporting System, Pharmaceutical Information Network database, Laboratory, and Electronic Medical Records. Hemoglobin A1c and diabetes medication details were used to classify diabetes groups into absent, prediabetes, meeting glycemic targets, and not meeting glycemic targets. The performance of ICD codes among these groups was compared to this standard. Within each group, the total numbers of true positives, false positives, false negatives, and true negatives were calculated. Descriptive statistics and bivariate analysis were conducted on identified covariates, including demographics and types of interacted physicians.ResultsA total of 12,012 NAFLD patients were registered through the Calgary NAFLD Pathway Database and 100% were successfully linked to the administrative databases. Overall, diabetes coding showed a sensitivity of 0.81 and a positive predictive value of 0.87. False negative rates in the absent and not meeting glycemic control groups were 4.5% and 6.4%, respectively, whereas the meeting glycemic control group had a 42.2% coding error. Visits to primary and outpatient services were associated with most encounters.ConclusionDiabetes ICD coding in administrative databases can accurately detect true diabetic cases. However, patients with diabetes who meets glycemic control targets are less likely to be coded in administrative databases. A detailed understanding of the clinical context will require additional data linkage from primary care settings.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease
    Seungwon Lee
    Abdel Aziz Shaheen
    David J. T. Campbell
    Christopher Naugler
    Jason Jiang
    Robin L. Walker
    Hude Quan
    Joon Lee
    BMC Health Services Research, 24
  • [2] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (22) : 855 - 862
  • [3] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (21) : 815 - 825
  • [4] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bawany, Muhammad Adnan
    Lashari, Naveed Aslam
    Soomro, Majid Ali
    Memon, Hamid Nawaz Ali
    Laghari, Fiza
    Irshad, Muntaha
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (07): : 6283 - 6286
  • [5] Non-alcoholic fatty liver disease in patients with diabetes mellitus
    Naini, Sohrab Rahimi
    Fuchs, Michael
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (05) : 503 - 514
  • [6] Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Kobayashi, Yukiko
    Tatsumi, Hina
    Hattori, Mikako
    Sugiyama, Hiroki
    Wada, Sayori
    Kuwahata, Masashi
    Tanaka, Saiyu
    Kanemasa, Kazuyuki
    Sumida, Yoshio
    Naito, Yuji
    Fukui, Michiaki
    Kido, Yasuhiro
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2016, 59 (03) : 215 - 219
  • [7] Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne
    Kosmidou, Maria
    Milionis, Haralampos
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 109 - 121
  • [8] Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?
    Targher, Giovanni
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (02) : 239 - 241
  • [9] TESTOSTERONE DEFICIENCY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN WITH TYPE 2 DIABETES MELLITUS
    Khripun, Irina A.
    Vorobyev, Sergey V.
    Allakhverdieva, Yanina S.
    DIABETES MELLITUS, 2019, 22 (06): : 542 - 549
  • [10] Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
    Luo, Yu
    Wang, Cuiyu
    Zhang, Tian
    He, Xiaoyu
    Hao, Jianan
    Shen, Andong
    Zhao, Hang
    Chen, Shuchun
    Ren, Luping
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 293 - 302